ArcticZymes Technologies ASA
OSL: AZT.OL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Oslo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael Benjamin Akoh
- Employees
- 54
- Headquarters
- Tromsø, Norway
- IPO year
- 2005
- Market cap
- NOK 1.0B
- Website
- https://arcticzymes.com
Loading AZT…
Loading profile data…Frequently asked questions about AZT
What does ArcticZymes Technologies ASA (AZT.OL) do?
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp al...
Where does AZT.OL trade?
ArcticZymes Technologies ASA (AZT.OL) trades on the Oslo Stock Exchange.
What sector is AZT.OL in?
ArcticZymes Technologies ASA (AZT.OL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ArcticZymes Technologies ASA?
Michael Benjamin Akoh is the chief executive officer of ArcticZymes Technologies ASA (AZT.OL).
Where is ArcticZymes Technologies ASA headquartered?
ArcticZymes Technologies ASA is headquartered in Norway.
Does AZT.OL pay a dividend?
ArcticZymes Technologies ASA (AZT.OL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AZT.OL go public?
ArcticZymes Technologies ASA (AZT.OL) completed its initial public offering in 2005.